Key result
HFrEF is linked to ~39% slower pulmonary oxygen uptake kinetics compared to HFpEF.
Case-Control (n=21)
Absolute Event Rate: 63% vs 45.4%
p-value: p=<0.05
HFrEF patients demonstrate more severely impaired oxygen kinetics and peripheral function during exercise compared to HFpEF patients, with body composition further influencing these parameters.
Suggests distinct peripheral limitations in HFrEF versus HFpEF; hypothesis-generating for body composition effects on exercise tolerance.
This study aims to (1) compare the kinetics of pulmonary oxygen uptake (VO2p), skeletal muscle deoxygenation ([HHb]), and microvascular O 2 delivery (QO 2 mv) between heart failure (HF) patients with reduced ejection fraction (HFrEF) and those with preserved ejection fraction (HFpEF), and (2) explore the correlation between body composition, kinetic parameters, and exercise performance. Twenty-one patients (10 HFpEF and 11 HFrEF) underwent cardiopulmonary exercise testing to assess VO 2 kinetics, with near-infrared spectroscopy (NIRS) employed to measure [HHb]. Microvascular O 2 delivery (QO 2 mv) was calculated using the Fick principle. Dual-energy X-ray absorptiometry (DEXA) was performed to evaluate body composition. HFrEF patients exhibited significantly slower VO 2 kinetics (time constant [t]: 63 ± 10.8 s vs. 45.4 ± 7.9 s; P < 0.05) and quicker [HHb] response (t: 12.4 ± 9.9 s vs. 25 ± 11.6 s; P < 0.05). Microvascular O2 delivery (QO 2 mv) was higher in HFrEF patients (3.6 ± 1.2 vs. 1.7 ± 0.8; P < 0.05), who also experienced shorter time to exercise intolerance (281.6 ± 84 s vs. 405.3 ± 96 s; P < 0.05). Correlation analyses revealed a significant negative relationship between time to exercise and both QO 2 mv (ρ= -0.51; P < 0.05) and VO2 kinetics (ρ= -0.63). Body adiposity was negatively correlated with [HHb] amplitude (ρ= -0.78) and peak VO 2 (ρ= -0.54), while a positive correlation was observed between lean muscle percentage, [HHb] amplitude, and tau (ρ= 0.74 and 0.57; P < 0.05), respectively. HFrEF patients demonstrate more severely impaired VO2p kinetics, skeletal muscle deoxygenation, and microvascular O 2 delivery compared to HFpEF patients, indicating compromised peripheral function. Additionally, increased adiposity and reduced lean mass are linked to decreased oxygen diffusion capacity and impaired oxygen uptake kinetics in HFrEF patients.
No takes yet. Share an insight, caveat, or question.
Cipriano et al. (2024) conducted a case-control in Heart Failure (HFrEF and HFpEF) (n=21). Heart failure with reduced ejection fraction (HFrEF) vs. Heart failure with preserved ejection fraction (HFpEF) was evaluated on Pulmonary oxygen uptake (VO2) kinetics time constant (τ) in seconds (p=<0.05). Patients with HFrEF exhibited significantly slower pulmonary oxygen uptake kinetics (time constant 63 vs 45.4 s) and quicker skeletal muscle deoxygenation response compared to patients with HFpEF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: